FDA Limits Use of J&J Vaccine Over Blood Clotting Disorder, But Experts Say Pfizer, Moderna Shots Pose Similar Risk
Via The Defender The U.S. Food and Drug Administration on Thursday put strict limits on the use of Johnson & Johnson’s COVID-19 vaccine, citing the risk of a blood clotting condition, but experts say that Pfizer and Moderna pose similar risks. By Julie Comber, Ph.D. The U.S. Food and Drug …
Read More